Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
24,447 total articles
TeraWulf announced a landmark 20-year lease agreement with Anthropic for its Justified Data campus in Kentucky, expected to generate approximately $19 billion in contracted revenue. Additionally, TeraWulf is selling its 50.1% interest in the Abernathy Joint Venture to Fluidstack, monetizing a $450 million investment at a premium and freeing capital…
Catheter Precision, a US-based medical device firm specializing in cardiac electrophysiology, announced the issuance of two critical patents covering its innovative technologies: one enhancing precise localization of ventricular tachycardia using implantable device data, and another improving heart failure treatment through electrical neuromodulati…
Indonesia Energy Corporation (NYSE American: INDO) announced the start of operations on its K-29 well at the Kruh Block in Sumatra, marking a significant milestone in its ongoing drilling program. Following this, the company plans to commence drilling at the WK-5 wellsite. IEC has submitted environmental clearances for an additional 30 wells by 203…
Quantum Cyber N.V., a Nasdaq-listed autonomous defense technology company, announced plans for its Bridgeport, Connecticut manufacturing facility to achieve an annual production capacity of approximately 100,000 drones spanning kamikaze, interceptor, surveillance, VTOL, and long-range platforms. This expansion supports the U.S. government's focus o…
ParaZero Technologies Ltd., an aerospace defense tech company specializing in autonomous aerial systems, announced a significant purchase order exceeding $1 million from a U.S.-based customer. This order underscores customer trust in ParaZero's technology and engineering expertise, supporting the company's expansion into advanced aerial systems mar…
PMGC Holdings Inc. announced the merger of its portfolio company AGA Precision Systems into A&B Aerospace, consolidating two precision manufacturing businesses within the aerospace sector. This strategic move is intended to simplify corporate structure, reduce administrative overhead, optimize resource sharing, and enhance operational efficiency, s…
SOLOWIN HOLDINGS (Nasdaq: AXG) announced that its subsidiary, AX Coin Bahrain, has signed a non-binding MOU with the Bank of Bahrain and Kuwait to explore developing regulated stablecoin infrastructure aimed at institutional payments, treasury operations, and cross-border settlements. This partnership seeks to leverage AX Coin's digital asset exper…
TG Therapeutics announced the start of a Phase 2 open-label clinical trial testing BRIUMVI (ublituximab-xiiy) in about 60 adults with treatment-resistant schizophrenia. This trial aims to assess the drug's efficacy and safety by measuring symptom improvement through standard clinical scales. BRIUMVI is already FDA-approved for relapsing multiple sc…
FreightCar America announced a milestone multi-year contract for 1,900 railcars through 2028 with a key customer, along with approximately 3,000 railcar orders in Q2 totaling around $300 million. This surge in orders across core market segments highlights growing demand and expanding backlog visibility, representing a commercial inflection point fo…
CervoMed Inc. presents five scientific presentations at the Alzheimer's Association International Conference 2026 detailing the clinical progress of neflamapimod, its leading oral drug candidate for treating dementia with Lewy bodies (DLB). Data suggest neflamapimod may slow disease progression, improve cognitive and functional outcomes, and impact…
Banzai International, an AI marketing technology company, has acquired ConnectAndSell, an AI sales acceleration platform serving 250 B2B organizations, for $13.2 million. The acquisition doubles Banzai's annual revenue by adding $14.7 million at an 86% gross margin and aims to create cross-selling opportunities, extend the company's revenue generat…
Kelly Services, a global workforce strategy provider, appointed Alan Stukalsky as Chief Product and Technology Officer. Stukalsky brings over 25 years of experience in technology leadership and digital transformation, aiming to drive AI integration and innovation across Kelly’s service portfolio, enhancing product strategy and operational excellenc…
Keel Infrastructure Corp., a North American digital infrastructure and energy company, has appointed Ganesh Aiyer as President. Aiyer brings significant expertise from Digital Realty Trust and other major tech companies, positioning Keel for long-term growth by expanding its commercial operations and power infrastructure development in high-demand …
Prospect Capital Corporation has completed a first lien senior secured term loan and equity-linked investment in ShipOffers, a leading on-demand product and order fulfillment company. This investment aims to support ShipOffers' growth through expansion of people, technology, and facilities, enhancing its ability to serve e-commerce and direct-to-co…
Invivyd announced receipt of a formal twelve-month advance notice from the FDA that the Emergency Use Authorization (EUA) for its COVID-19 monoclonal antibody treatment PEMGARDA will terminate on June 29, 2027, following the Department of Health and Human Services' planned end to the COVID-19 EUA declaration. Invivyd is engaging with FDA on next re…
Quantum Cyber N.V. responded to a recent short-seller report which it claims contains misleading information on its capital structure, business strategy, and technology partnerships. The Company emphasized full disclosure in its SEC filings, outlined its autonomous defense technology initiatives including patent filings, addressed its relationship …
VERAXA Biotech AG has provided a mid-2026 business update highlighting substantial progress in developing its novel BiTAC® technology and pipeline, focusing on BiTAC T cell engagers for solid tumors. The company aims to have an IND/CTA-ready candidate by early 2028 while planning to monetize non-BiTAC assets to finance growth. Ongoing industry inte…
Opus Genetics announced FDA alignment on the Phase 3 registrational trial design for their gene therapy OPGx-LCA5 targeting LCA5-associated inherited retinal disease, an ultra-rare form of childhood blindness. The FDA permits a Biologics License Application submission based on six-month efficacy data, with durability data at 12 months to complete t…
NN, Inc. announced a significant milestone in its Medical Products business by becoming qualified and receiving initial purchase orders to manufacture critical components for a leading robotic-assisted surgery platform. This breakthrough is part of NN's targeted growth strategy in medical markets and adds approximately $25 million to its medical ne…
Wrap Technologies announced that the ATF has issued a ruling formally classifying its BolaWrap 150 device as an instrument of restraint rather than a firearm or weapon under federal law. This classification removes regulatory uncertainty, potentially streamlining procurement processes and expanding accessible markets across corrections, civilian sa…
Seer, Inc. filed an investor presentation emphasizing its leadership in deep proteomics technology with significant commercial potential and advancing AI-driven precision medicine. The company reports strong growth metrics, a robust innovation pipeline, cost discipline, and a highly qualified, independent board urging stockholders to support its di…
Belite Bio, a clinical-stage biotech company, announced that data from its Phase 3 DRAGON trial of Tinlarebant, an oral therapy targeting retinal degenerative diseases, will be presented at upcoming international medical conferences. Tinlarebant aims to treat Stargardt Disease by reducing toxic vitamin A derivatives in the eye. The drug has receive…
Aurora Mobile Limited (NASDAQ: JG) has partnered with Pobo Financial to implement its JPush intelligent push notification technology across Pobo Financial's mobile apps. This collaboration aims to improve the timeliness, reliability, and stability of delivering critical financial information and alerts, especially for derivatives market investors w…
Can-Fite BioPharma has completed enrollment of 247 patients in its pivotal Phase 3 trial for Piclidenoson, an oral treatment for moderate-to-severe plaque psoriasis. The study, designed in agreement with the FDA and EMA, will undergo interim analysis evaluating efficacy and safety, with results expected in late 2026 or early 2027. Piclidenoson's or…
Descartes Systems Group announced the acquisition of Drivin, a Latin American delivery management platform, to enhance its AI-powered last mile logistics and expand its Global Logistics Network in Latin America. This acquisition strengthens Descartes' position in the logistics technology sector by leveraging Drivin's advanced route optimization, di…
